Shengjia Shi
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Immunology
- Pulmonary and Respiratory Medicine
- Topics
- Prostate Cancer Treatment and Research (6 papers)Cancer-related molecular mechanisms research (4 papers)RNA Research and Splicing (4 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- ChinaUnited States
In The Last Decade
Shengjia Shi
24 papers receiving 938 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 448
- Cancer Research 391
- Oncology 256
- Immunology 211
- Pulmonary and Respiratory Medicine 162
Countries citing papers authored by Shengjia Shi
This map shows the geographic impact of Shengjia Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjia Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjia Shi more than expected).
Fields of papers citing papers by Shengjia Shi
This network shows the impact of papers produced by Shengjia Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjia Shi. The network helps show where Shengjia Shi may publish in the future.
Co-authorship network of co-authors of Shengjia Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Shengjia Shi. A scholar is included among the top collaborators of Shengjia Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengjia Shi. Shengjia Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 11 | |
| 6 | 11 | |
| 7 | 18 | |
| 8 | 9 | |
| 9 | 20 | |
| 10 | 26 | |
| 11 | 3 | |
| 12 | 10 | |
| 13 | 57 | |
| 14 | 44 | |
| 15 | 17 | |
| 16 | 55 | |
| 17 | [miR-590-5p inhibits A375 cell invasion and migration in malignant melanoma by directly inhibiting YAP1 expression]. | 4 |
| 18 | 271 | |
| 19 | 80 | |
| 20 | 149 |
About Shengjia Shi
Shengjia Shi is a scholar working on Cancer Research, Reproductive Medicine and Immunology and Allergy, having authored 25 papers that have together received 944 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Cancer-related molecular mechanisms research (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (391 citations), Immunology (211 citations) and Oncology (256 citations). Shengjia Shi has collaborated with scholars based in China and United States. Frequent co-authors include Lijuan Wang, Weihong Wen, Yunhui Li, Yong Jin, Bo Yu, Angang Yang, Zhangyan Guo, Ming Wei, Donghui Han and Yan–Ling Meng. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.